Skip to main content

Peer Review reports

From: Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

Original Submission
22 May 2018 Submitted Original manuscript
6 Jul 2018 Reviewed Reviewer Report - Sophie Willemse
14 Aug 2018 Reviewed Reviewer Report - Karin Neukam
1 Nov 2018 Author responded Author comments - Anne Laurain
Resubmission - Version 2
1 Nov 2018 Submitted Manuscript version 2
13 Dec 2018 Reviewed Reviewer Report - Karin Neukam
7 Jan 2019 Reviewed Reviewer Report - Sophie Willemse
4 Feb 2019 Author responded Author comments - Anne Laurain
Resubmission - Version 3
4 Feb 2019 Submitted Manuscript version 3
16 Mar 2019 Author responded Author comments - Anne Laurain
Resubmission - Version 4
16 Mar 2019 Submitted Manuscript version 4
Publishing
19 Mar 2019 Editorially accepted
2 Apr 2019 Article published 10.1186/s12879-019-3923-5

You can find further information about peer review here.

Back to article page